Tobacco Use Treatment at the U.S. National Cancer Institute's Designated Cancer Centers by Goldstein, Adam O. et al.
doi:10.1093/ntr/nts083
Advance Access publication April 11, 2012
© The Author 2012. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.  
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Nicotine & Tobacco Research, Volume 15, Number 1 (January 2013) 52–58
52 1
: 10.1093/ntr/nts083
 © The Author 2012. Publ shed by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. 
All rights reserved. For permissions, please e-mail: journals.permissions@oup. om 
shorter recurrence-free survival ( Fleshner et al., 1999 ) and 
greater risk for a second primary tumor ( Do et al., 2004 ; 
 Johnson, 1998 ;  Tucker et al., 1997 ). Smoking is also associated 
with worse outcomes and increased costs of care following cancer 
surgery. Continued smoking impairs quality of life across 
physical, psychological, and social domains ( Garces et al., 2004 ). 
 Cancer centers and the clinicians and staff who work there 
should help cancer patients who use tobacco quit and help them 
eliminate exposure to secondhand smoke. Even though many 
cancer patients continue to smoke, a majority express interest in 
getting help to stop ( Cooley et al., 2011 ) and signifi cant num-
bers feel ready to quit ( Sanderson Cox et al., 2002 ;  Schnoll et al., 
2003 ,  2004 ). The 2008 Clinical Practice Guideline emphasizes 
combining medication and counseling to signifi cantly increase 
quit rates for all patients who want to stop smoking ( Fiore et al., 
2008 ). Key recommendations from the guideline include con-
sistent identifi cation and documentation of tobacco use, initia-
tion of treatment for every tobacco user seen in a health care 
setting, and broad dissemination of these treatment guidelines 
into all health care clinical organizations. 
 The National Cancer Institute (NCI) awards substantive 
grants to support designated Cancer Centers across the U nited 
 S tates that model transdisciplinary translational cancer 
research. It views these Cancer Centers as the centerpiece of 
efforts to reduce morbidity and mortality from cancer. Some 
combination of three principal focus areas — laboratory 
science, clinical research, and population science — is required 
for NCI designation ( National Cancer Institute, 2010 ). In 2009, 
the NCI website listed 65 designated Cancer Centers ( National 
Cancer Institute, 2009 ). Forty of these, exhibiting work in all 
three focus areas, were labeled Comprehensive Cancer Centers. 
Of the remaining 25 Cancer Centers,  7 Centers did not engage 
in clinical research and therefore provided no direct patient 
care services. 
 Given their visibility and status as champions in cancer con-
trol efforts, these designated Centers and their providers should 
be leading by example in all areas of cancer care and prevention, 
 Abstract 
 Introduction:  Tobacco use is a leading cause of cancer, and 
continued use after cancer diagnosis puts patients at greater risk 
for adverse health outcomes, including increased risk for cancer 
recurrence. This study surveyed National Cancer Institute 
(NCI) – designated Cancer Centers to assess the availability of 
tobacco use treatment (TUT) services. 
 Methods:  Directors and oncology providers of 58 NCI-
designated Cancer Centers received invitations to participate in 
an online survey. The questionnaire asked about attitudes, 
awareness, policies, and practices related to TUT; barriers to 
treatment provision; and factors likely to increase services. 
 Results:  All 58 Cancer Centers participated. Twelve (20.7%) 
Centers reported no TUT services for their patients. Of the 
remainder, 34 (58.6%) reported a TUT program within their 
Center and 12 (20.7%) reported external TUT services in their 
health care system or affi liated university. Only 62% of Centers 
reported routinely providing tobacco education materials to 
patients, just over half reported effective identifi cation of patient 
tobacco use, and less than half reported an employee dedicated 
to providing TUT services or a clear commitment to providing 
TUT services from Center leadership. The 34 centers with inter-
nal TUT programs reported signifi cantly greater services and 
administration support for TUT Services. 
 Conclusions:  These data demonstrate a national need for 
Cancer Centers to embrace and incorporate recommended 
standards for TUT. Tying TUT services to NCI recognition and 
providing stable funding for TUT services in Cancer Centers 
could lead to better health outcomes, treatment effi cacy, and 
satisfaction for all U.S. Cancer Centers and their patients. 
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 Patients who continue to smoke after a cancer diagnosis are at 
greater risk for a range of adverse health outcomes, including 
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Tobacco use treatment at U.S. NCI Cancer Centers
including implementing recommended evidence-based tobacco 
use treatment  (TUT)  for patients under their care. To date, no 
studies have assessed the kinds and extent of tobacco treatment 
services offered by NCI-supported Cancer Centers. 
 This study sought to learn what NCI Cancer Centers are 
currently doing to address tobacco use in their patients and 
staff. It identifi es the characteristics of Centers that provide 
active  TUT programs and the barriers that may prevent Cancer 
Centers from offering more tobacco treatment services. 
 Methods 
 The study utilized a cross - sectional design, gathering web-based 
survey data in October 2009 from key staff of 58 NCI - designated 
Cancer Centers. Unless otherwise noted, the term  “ Cancer 
Centers ” includes the 40 Comprehensive Cancer Centers 
and the additional 18 Cancer Centers, all of  which offered direct 
patient care services. 
 Questionnaire  D evelopment 
 The questionnaire assessed recognized components of effective 
TUT and the facilitators and barriers to implementing the 
interventions recommended by the Clinical Practice Guidelines. 
An NCI working group on treating tobacco use within Cancer 
Centers helped draft a pilot instrument. The fi nal 44-item ques-
tionnaire included demographic questions, questions about 
respondents ’ awareness, opinions, and involvement in TUT in 
their Cancer Center, and questions about TUT programs 
within Centers to support patients in tobacco cessation. 
Those reporting TUT services within the Cancer Center were 
asked about sources of funding and the administrative home 
for such services. Respondents answering  “ no ” or  “ unsure ” 
when asked about the availability of in-house services were 
asked if TUT services were available through their affiliated 
university or health care system. They were also asked about 
the likelihood of their Cancer Center instituting a TUT pro-
gram in the next year. 
 Respondents identifi ed the specifi c practices related to TUT 
currently offered by their Centers. These included routinely 
identifying tobacco use as a vital sign in medical records , having 
designated individual(s) to provide TUT , offering employee 
programs for TUT , supporting quality improvement measures 
related to TUT , having environmental policies in place to sup-
port tobacco use cessation (e.g., 100% tobacco - free grounds 
policy) , having local champions to promote TUT treatment 
efforts , and offering research programs in tobacco control. 
 Fielding the  S urvey 
 The survey goal was to ensure  that  we obtained a respondent 
who demonstrated knowledge about the availability or lack 
thereof for TUT services in every Cancer Center. After pilot 
testing, the questionnaire was sent by email from the director of 
the U niversity of  N orth  C arolina Lineberger Cancer Center to 
the directors of the other 57 NCI Cancer Centers. We antici-
pated that some directors or their designees might not respond 
or have little awareness of the TUT services in their Center. To 
increase the likelihood of accurate information from every 
Cancer Center, questionnaires were also emailed to one radia-
tion oncologist and one medical oncologist in either the head 
and neck or thoracic departments at each Cancer Center. These 
providers were identifi ed through information provided by 
directors on their returned questionnaires or on Cancer Centers ’ 
websites. Those who did not respond to the initial email contact 
received up to two reminder emails. The Public Health-Nursing 
Institutional Review Board of the University of North Carolina 
at Chapel Hill determined that this project did not constitute 
human subjects research. 
 Survey Respondents 
 From the distributed surveys, we received 48 responses from 
either the director or the director ’ s designee and 62 responses 
from oncology treatment providers. We received at least one 
response from every Cancer Center and received more than 
one response from 60% of Centers. For analysis, we used data 
from only one respondent from each Cancer Center , choosing 
the director or director ’ s designee in all cases unless compel-
ling information from returned questionnaires recommended 
another, better informed respondent. Our protocol defi ned 
compelling as satisfying one of the following conditions: either 
the oncology treatment respondent ’ s combined awareness and 
involvement were greater than that of the director or the director 
indicated a high number of unsure responses. Final analyses 
are based on responses from 43 directors or their designees and 
15 oncology providers with highest awareness of TUT services 
at their center. Additional data for each Cancer Center was 
assembled from the NCI ’ s website, specifically about Cancer 
Center designation and the amount of NCI funding received 
in 2008. 
 Analysis 
 All quantitative data were entered into SPSS 17.0 and initially 
presented through frequency distributions. Bivariate associa-




 Respondents (the 43 directors/designees and 15 oncology 
providers) were predominantly male (65%) and had served in 
their Cancer Center for more than  ten years (43%). Almost a 
third (31%) of respondents indicated their primary Cancer 
Center role to be director, with an additional 17% indicating 
other signifi cant administrative roles (e.g., medical director, 
research program director, tobacco treatment program director). 
Twenty-six percent reported their primary role as physicians, 
17% as researchers, and 5% as  TUT clinicians. 
 Attitudes and Knowledge  A bout TUT 
Services 
 Virtually all (97%) respondents indicated they felt that pro-
viding TUT services to cancer patients was important or very 
important. Eighty-eight percent thought  that  they were very or 
highly aware of their Cancer Center policies and services related 
to tobacco use, and 59% reported that they were personally 
“very” or “highly” involved in ensuring these tobacco treatment 
services and policies were in place. Only 48% of respondents 
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indicated  that  they had substantive knowledge about the U . S . Health 
and Human Services clinical practice guidelines related to TUT. 
 TUT Programs 
 When asked if their Cancer Center had a TUT program for 
patients, 34 (58.6%) responded  y es. Of the remaining Centers, 
12 (20.7%) reported a TUT program within the health care 
system or affi liated university to which patients could be referred, 
and 12 (20.7%) reported  n o program or being unsure about 
affi liated TUT programs. Respondents stated that their Cancer 
Center – based TUT programs were administratively housed in a 
variety of clinics and departments, the most common being 
patient support services (24%), free standing tobacco research 
programs (15%), and prevention and control research programs 
(15%). Other bases for housing TUT services included clinics 
within psychiatry, family medicine, pulmonary medicine, and 
multidisciplinary clinics. 
 Most respondents for the 34 Cancer Centers that offered 
TUT programs reported that internal funding sources supported 
their programs. The second most often cited source of support 
was through federal grants (50%). Eighty-fi ve percent of TUT 
programs reported multiple sources of funding. 
 Of the 24 programs reporting no cancer center TUT pro-
gram,  seven (29%) reported that their cancer center would likely 
or very likely institute a TUT program within the next year. 
 Current Cancer Center Policy and 
Practice 
 Figure 1 displays the percentage of respondents reporting spe-
cifi c system policies and programs that support  TUT . Having 
smoke-free campus policies and a tobacco use research program 
were each reported by over 75% of all respondents. Slightly 
more than half reported an employee treatment program or a 
physician champion to promote  TUT . Less than half reported a 
person(s) whose designated role involved  TUT or coordination, 
tobacco use as a vital sign, or the use of any tobacco measure in 
quality improvement. For comparison, 78% of responding 
Cancer Centers reported having a designated individual who 
provides nutritional counseling to their patients. 
 Components of adopting and implementing recommended 
TUT ( Bradley et al., 2001 ,  Fiore et al., 2008 ,  Partnership for 
Prevention, 2008 ) and the percent of responding centers report-
ing these can be found in  Figure 2 . Other than providing 
tobacco education materials, no recommended TUT practice 
was found in more than 60% of Cancer Centers. Less than half 
of respondents believed that there was clear commitment to 
TUT services from Center leadership or that providers received 
adequate training in TUT. Less than a third believed that their 
Center actively promoted either TUT to family members 
or utilization of quitline fax referrals. Few (9%) reported that 
clinicians were offered regular feedback on how they identify, 
refer, or counsel patients who use tobacco. 
 Table 1 shows that Cancer Centers with a TUT program 
within their Center ( n  =  34), compared  with those without 
such a program ( n  =  24), were more likely to report a broad 
array of many meaningful TUT services, such as on-site coor-
dination and provision of TUT , and systems for identifi cation 
of inpatient and outpatient tobacco use among cancer pa-
tients. Centers with a TUT program were also signifi cantly 
more likely to have strong administrative support for TUT, 
such as communication to staff, a clear commitment from 
leadership, and champions who made TUT a major part of 
their professional role. 
 Improving TUT  S ervices 
 Factors that respondents indicated would improve TUT services 
in their Cancer Center are reported in  Figure 3 , with the top 
three factors being provision of stable funding, qualifi ed tobacco 
treatment specialists  (TTS)  on staff , and adequate space. These 
suggested improvements were recommended by the majority of 
respondents from Centers with and without a TUT program in 
their Center. 
 Discussion 
 This study provides the first comprehensive look at TUT 
practices at NCI Cancer Centers. While this study shows 
that the majority of directors and key leadership of NCI 
Cancer Centers believe that TUT services are important and 
have TUT research programs, many do not provide recom-
mended evidenced-based tobacco cessation services to their 
cancer patients. A sizable minority offer their patients no 
TUT services. 
  
 Figure 1.  Percent of Centers reporting policies and programs to support tobacco use treatment ( n  =  58) . 
4
Tobacco use treatment at U.S. NCI Cancer Centers
 Based on our results, the following recommendations 
should be considered:
 1.  All Cancer Centers who treat patients should have a 
TUT program within their center. 
 Cancer Centers exist to effectively treat cancer patients, to 
prevent future cancer recurrences, and to conduct research 
on cancer treatment and prevention. Given that tobacco use is 
a leading cause of cancer and a signifi cant cause of morbidity 
and mortality following a cancer diagnosis, TUT program 
availability to Center patients should be central to the mission 
  
 Figure 2.  Percent of Centers reporting components of adopting and implementing recommended TUT ( n  =  58) . 
 Table 1.  Percent of Cancer Centers 
Reporting TUT Components, by Centers 
With and Without a TUT Program ( n = 58) 
 Components related to tobacco use treatment 





 n = 34  n = 24 
 Yes (%) No (%) 
 Routine provision of patient education materials 79* 38 
 Designated person who provides TUT 76* 8 
 Cancer center has tobacco research program 76 75 
 Offers employee program for staff/faculty 74 54 
 Has a champion for TUT 74** 46 
 Clear commitment from leadership 71* 13 
 Good communication to staff 68** 33 
 Effective identifi cation of outpatient tobacco use 62 42 
 Effective identifi cation of inpatient tobacco use 62 37 
 Designated person who coordinates TUT 76* 8 
 Adequate provider training 41 25 
 Identifi es tobacco use as vital sign in medical 
  record
38 38 
 Active TUT promotion to family members 38** 13 
 Tracks quality improvement measures TUT 35 17 
 Active promotion of fax referral 29 13 
 Regular feedback to clinicians 9 8 
 Note.  TUT = tobacco use treatment. 
 * p  <  .001 .  ** p  <  .05 . 
of all Cancer Centers. Literature also indicates that cancer 
patients benefi t from specialized services to help them quit 
smoking ( McBride & Ostroff, 2003 ). Given the positive 
impacts on cancer patients, family members, and staff, it 
is surprising that comprehensive TUT is not uniformly 
integrated into all Centers. Since Centers that have a TUT 
program appear to provide signifi cantly more meaningful 
TUT services and enjoy stronger administrative support, all 
Cancer Centers without a TUT program should have one 
within their Center. 
 The 2008 U. S. Department of Health and Human 
Services’ Treating Tobacco Use and Dependence Clinical Practice 
Guideline promotes dissemination of effective TUT medica-
tions and counseling strategies, as well as care for specific 
populations, including cancer patients ( Fiore et al., 2008 ). 
Having a TUT program within a cancer center will increase 
Cancer Center providers ’ familiarity with best practices in 
 TUT , a foundational step in helping the Centers incorporate 
evidence-based tools to support cancer patients in becoming 
tobacco free.
 2.  The NCI should facilitate the incorporation of TUT 
services into Cancer Center care. 
 The NCI can play a pivotal role in helping their designated 
Cancer Centers offer TUT programs. Since tobacco research 
programs in and of themselves were not related to the 
provision of TUT services, research on tobacco addiction, 
while desirable, is not suffi cient to ensure service provision. 
NCI Cancer Centers, recognized as leaders in cancer treatment 
and research, cannot be seen as offering substandard care 
when it comes to treating tobacco use, a highly addictive be-
havior that causes cancer, compromises cancer treatment, and 
increases risk of cancer recurrence. To begin changing this 
paradigm, the NCI sponsored a conference in 2009, attended 
by representatives from over three dozen Cancer Centers, to 
discuss collaboration and research for TUT ( Morgan et al., 
2011 ). This conference highlighted model programs to serve as 
best practices in providing guidance to Cancer Centers as they 
develop or expand TUT services. Further promotion of TUT 
services may occur if quality indicators for NCI Center desig-
nation and funding include published, evidenced-based TUT 
guidelines. Providing recommended care in this vital area 
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refer, or counsel patients who use tobacco. 
 Table 1 shows that Cancer Centers with a TUT program 
within their Center ( n  =  34), compared  with those without 
such a program ( n  =  24), were more likely to report a broad 
array of many meaningful TUT services, such as on-site coor-
dination and provision of TUT , and systems for identifi cation 
of inpatient and outpatient tobacco use among cancer pa-
tients. Centers with a TUT program were also signifi cantly 
more likely to have strong administrative support for TUT, 
such as communication to staff, a clear commitment from 
leadership, and champions who made TUT a major part of 
their professional role. 
 Improving TUT  S ervices 
 Factors that respondents indicated would improve TUT services 
in their Cancer Center are reported in  Figure 3 , with the top 
three factors being provision of stable funding, qualifi ed tobacco 
treatment specialists  (TTS)  on staff , and adequate space. These 
suggested improvements were recommended by the majority of 
respondents from Centers with and without a TUT program in 
their Center. 
 Discussion 
 This study provides the first comprehensive look at TUT 
practices at NCI Cancer Centers. While this study shows 
that the majority of directors and key leadership of NCI 
Cancer Centers believe that TUT services are important and 
have TUT research programs, many do not provide recom-
mended evidenced-based tobacco cessation services to their 
cancer patients. A sizable minority offer their patients no 
TUT services. 
  
 Figure 1.  Percent of Centers reporting policies and programs to support tobacco use treatment ( n  =  58) . 
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 Based on our results, the following recommendations 
should be considered:
 1.  All Cancer Centers who treat patients should have a 
TUT program within their center. 
 Cancer Centers exist to effectively treat cancer patients, to 
prevent future cancer recurrences, and to conduct research 
on cancer treatment and prevention. Given that tobacco use is 
a leading cause of cancer and a signifi cant cause of morbidity 
and mortality following a cancer diagnosis, TUT program 
availability to Center patients should be central to the mission 
  
 Figure 2.  Percent of Centers reporting components of adopting and implementing recommended TUT ( n  =  58) . 
 Table 1.  Percent of Cancer Centers 
Reporting TUT Components, by Centers 
With and Without a TUT Program ( n = 58) 
 Components related to tobacco use treatment 





 n = 34  n = 24 
 Yes (%) No (%) 
 Routine provision of patient education materials 79* 38 
 Designated person who provides TUT 76* 8 
 Cancer center has tobacco research program 76 75 
 Offers employee program for staff/faculty 74 54 
 Has a champion for TUT 74** 46 
 Clear commitment from leadership 71* 13 
 Good communication to staff 68** 33 
 Effective identifi cation of outpatient tobacco use 62 42 
 Effective identifi cation of inpatient tobacco use 62 37 
 Designated person who coordinates TUT 76* 8 
 Adequate provider training 41 25 
 Identifi es tobacco use as vital sign in medical 
  record
38 38 
 Active TUT promotion to family members 38** 13 
 Tracks quality improvement measures TUT 35 17 
 Active promotion of fax referral 29 13 
 Regular feedback to clinicians 9 8 
 Note.  TUT = tobacco use treatment. 
 * p  <  .001 .  ** p  <  .05 . 
of all Cancer Centers. Literature also indicates that cancer 
patients benefi t from specialized services to help them quit 
smoking ( McBride & Ostroff, 2003 ). Given the positive 
impacts on cancer patients, family members, and staff, it 
is surprising that comprehensive TUT is not uniformly 
integrated into all Centers. Since Centers that have a TUT 
program appear to provide signifi cantly more meaningful 
TUT services and enjoy stronger administrative support, all 
Cancer Centers without a TUT program should have one 
within their Center. 
 The 2008 U. S. Department of Health and Human 
Services’ Treating Tobacco Use and Dependence Clinical Practice 
Guideline promotes dissemination of effective TUT medica-
tions and counseling strategies, as well as care for specific 
populations, including cancer patients ( Fiore et al., 2008 ). 
Having a TUT program within a cancer center will increase 
Cancer Center providers ’ familiarity with best practices in 
 TUT , a foundational step in helping the Centers incorporate 
evidence-based tools to support cancer patients in becoming 
tobacco free.
 2.  The NCI should facilitate the incorporation of TUT 
services into Cancer Center care. 
 The NCI can play a pivotal role in helping their designated 
Cancer Centers offer TUT programs. Since tobacco research 
programs in and of themselves were not related to the 
provision of TUT services, research on tobacco addiction, 
while desirable, is not suffi cient to ensure service provision. 
NCI Cancer Centers, recognized as leaders in cancer treatment 
and research, cannot be seen as offering substandard care 
when it comes to treating tobacco use, a highly addictive be-
havior that causes cancer, compromises cancer treatment, and 
increases risk of cancer recurrence. To begin changing this 
paradigm, the NCI sponsored a conference in 2009, attended 
by representatives from over three dozen Cancer Centers, to 
discuss collaboration and research for TUT ( Morgan et al., 
2011 ). This conference highlighted model programs to serve as 
best practices in providing guidance to Cancer Centers as they 
develop or expand TUT services. Further promotion of TUT 
services may occur if quality indicators for NCI Center desig-
nation and funding include published, evidenced-based TUT 
guidelines. Providing recommended care in this vital area 
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would further set these Cancer Centers apart, improve cancer 
prevention and treatment efforts in these Centers, and acceler-
ate diffusion of such services to other cancer programs across 
the U nited  S tates .
 3.  Cancer centers should embrace new quality improve-
ment measures and opportunities for TUT services. 
 Increasingly, the gold standard for  TUT includes compre-
hensive on-site services for patients, training of providers, and 
quality improvement initiatives to improve outcomes. Quality 
improvements include system changes that ensure identifi ca-
tion of all tobacco users as well as provision of evidence - based 
treatment. Consistent identifi cation, such as making tobacco 
use a vital sign, results in more advice to quit and more coun-
seling ( McCullough, Fisher, Goldstein, Kramer, & Ripley-Moffi tt, 
2009 ). An added incentive for including regular identifi cation 
and treatment for tobacco users comes from the current 
Meaningful Use of Data guidelines, which outline requirements 
for receipt of funds through the American Recovery and Rein-
vestment Act 2009 ( U.S. Government, 2009 ). These guidelines 
include tobacco measures that track tobacco use identifi cation 
and treatment for both eligible health care organizations and 
providers. The Joint Commission currently mandates  TUT 
for inpatients with pneumonia, acute myocardial infarction, 
and heart failure. As of January 1, 2012, a new Joint Com m is-
sion tobacco measure set expands TUT services to all tobacco 
users, regardless of diagnosis ( Joint Commission, 2011 ). Cana-
dian hospitals, adopting the Ottawa Model of Smoking Cessa-
tion, have shown impressive results from offering TUT, 
improving quality of care across multiple hospital settings 
( Reid et al., 2010 ). 
 Our data indicate that even among those Centers that 
have a TUT program, significant room exists for improve-
ment in on-site counseling, as feedback systems to clinicians 
are particularly uncommon. Giving feedback to individual 
physicians or clinics on the care they provide has shown to 
be effective in changing physician behavior ( Bradley et al., 
2001 ). Cancer Center administrators should work with 
information technology staff to produce reports on tobacco 
use identification and treatment for feedback to providers 
and the institution. 
 Improving TUT outcomes in Cancer Centers will also 
involve training and support of providers and administrators, as 
provision of TUT to cancer patients poses some unique chal-
lenges not found when providing similar services to other out-
patient populations. These unique challenges include: beliefs 
among some Center providers that TUT is the responsibility of 
the primary care provider, lack of training among oncologists 
for how to provide TUT, management of pharmacotherapy for 
patients with complex treatment regimens, and the physical, 
psychological, and spiritual issues related to facing cancer diag-
nosis and treatment ( McBride & Ostroff, 2003 ).
 4.  Insititutional funding should support TUT services in 
Cancer Centers. 
 Perceived barriers to augmentation of TUT services in all 
Centers included shortages of funding, trained personnel, 
and space. Obtaining these resources, especially the funding 
required to sustain a program, is made more diffi cult because of 
the limited reimbursement currently available for such services. 
TTS offer more in-depth, individualized, and comprehensive 
treatment than that which physicians or nurses can incorporate 
into their already extensive clinic visit agendas. As members 
of the health care team, TTS can disseminate new treatment 
approaches and work on quality improvement around tobacco 
use ( Hurt, Ebbert, Hays, & McFadden, 2009 ). Providing a 
mechanism that will allow TTS to bill for their services will 
greatly enhance the sustainability of their involvement with 
Centers and ensure continuity of care for patients. 
 Limitations 
 This study has several limitations. Because we used data from 
only one respondent per center, there is the possibility that 
others would have interpreted or responded to questions dif-
ferently. It is possible that some respondents, perhaps direc-
tors or their designees, may have overstated their awareness 
and regard for TUT services because of the need to appear 
informed, thus potentially overstating program availability. 
Further more , because we measured self-reports of quality 
and effectiveness, variations in the nature and breadth of 
TUT programs (e.g., number of staff, reach of program) are 
not compared. 
  
 Figure 3.  Factors perceived “likely” or “very likely” to improve tobacco use treatment services at Cancer Centers ( n  =  58) . 
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 Conclusions 
 NCI Cancer Centers are increasingly interested in offering TUT 
programs as part of their core patient services. Nevertheless, TUT 
programs appear to lag behind other commonly accepted Cancer 
Center services, such as nutrition counseling. Having sustainable 
TUT programs at all Cancer Centers will improve Centers ’ qual-
ity of cancer care and has the potential to reduce morbidity and 
mortality related to tobacco use among cancer patients. 
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quality improvement initiatives to improve outcomes. Quality 
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have a TUT program, significant room exists for improve-
ment in on-site counseling, as feedback systems to clinicians 
are particularly uncommon. Giving feedback to individual 
physicians or clinics on the care they provide has shown to 
be effective in changing physician behavior ( Bradley et al., 
2001 ). Cancer Center administrators should work with 
information technology staff to produce reports on tobacco 
use identification and treatment for feedback to providers 
and the institution. 
 Improving TUT outcomes in Cancer Centers will also 
involve training and support of providers and administrators, as 
provision of TUT to cancer patients poses some unique chal-
lenges not found when providing similar services to other out-
patient populations. These unique challenges include: beliefs 
among some Center providers that TUT is the responsibility of 
the primary care provider, lack of training among oncologists 
for how to provide TUT, management of pharmacotherapy for 
patients with complex treatment regimens, and the physical, 
psychological, and spiritual issues related to facing cancer diag-
nosis and treatment ( McBride & Ostroff, 2003 ).
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 Conclusions 
 NCI Cancer Centers are increasingly interested in offering TUT 
programs as part of their core patient services. Nevertheless, TUT 
programs appear to lag behind other commonly accepted Cancer 
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